HKBU-led researchers develop EBV drug for nasopharyngeal cancer

A research team headed by Hong Kong Baptist University (HKBU) claims to have developed a novel anti-Epstein-Barr virus (EBV) drug for the treatment of nasopharyngeal ... Read More